Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENOX1 antisense RNA 1 (ENOX1-AS1) is a non-coding RNA transcribed opposite to the ENOX1 gene. There is limited or no experimental evidence that ENOX1-AS1 is a therapeutic target, encodes a protein, or plays a direct role in disease or cellular pathways. Most functional and therapeutic interest in this locus relates to the ENOX1 gene itself, which encodes an NADH oxidase/protein disulfide-thiol exchanger implicated in angiogenesis and cancer, not to the antisense RNA. Therefore, ENOX1-AS1 is not a receptor, enzyme, transporter, or other traditional target, and there may be confusion or error in referencing it as a direct drug target. Note: If you require information on the functional protein/enzyme target, look up "Ecto-NOX disulfide-thiol exchanger 1 (ENOX1)" rather than ENOX1-AS1.
None established
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ENOX1 antisense RNA 1 (ENOX1-AS1).